Regeneron to buy 23andMe out of bankruptcy for $256 million
Regeneron has agreed to buy 23andMe, the once buzzy genetic testing company, out of bankruptcy for $256 million under a court-supervised sale process. 23andMe declared bankruptcy in March and announced it would seek a buyer, while also…